US Stock MarketDetailed Quotes

CNBX CNBX Pharmaceuticals

Watchlist
  • 0.009000
  • 0.0000000.00%
15min DelayClose Feb 25 12:25 ET
280.00KMarket Cap-0.60P/E (TTM)

CNBX Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
(Q2)Feb 29, 2024
(Q1)Nov 30, 2023
(FY)Aug 31, 2023
(Q4)Aug 31, 2023
(Q3)May 31, 2023
(Q2)Feb 28, 2023
Total revenue
0
-68.29%130.07K
0
0
40.64K
89.44K
1,269.13%410.17K
233.80%100K
310.17K
0
Operating revenue
--0
-68.29%130.07K
--0
--0
--40.64K
--89.44K
1,269.13%410.17K
233.80%100K
--310.17K
--0
Cost of revenue
6.22K
0
Gross profit
34.42K
0
Operating expense
-85.90%36.84K
-46.84%713.21K
-79.91%52.53K
-68.49%152.28K
-3.67%240.85K
-24.64%261.34K
-55.04%1.34M
-48.56%261.5K
-23.90%483.25K
-65.76%250.01K
Selling and administrative expenses
-75.26%36.84K
-43.03%518.43K
-24.84%126.47K
-50.31%109.39K
-43.77%133.65K
-47.55%148.92K
-49.46%909.98K
-51.19%168.26K
-42.96%220.13K
-40.53%237.68K
-Selling and marketing expense
----
--0
----
----
----
----
-92.35%1.22K
----
----
----
-General and administrative expense
-75.26%36.84K
-42.95%518.43K
-24.29%126.47K
-50.31%109.39K
-43.77%133.65K
-47.55%148.92K
-49.08%908.76K
-49.19%167.04K
-42.96%220.13K
-40.53%237.68K
Research and development costs
--0
-54.86%194.79K
-179.30%-73.93K
-83.70%42.88K
769.56%107.2K
78.76%112.42K
-63.53%431.57K
-43.01%93.24K
5.64%263.12K
-96.27%12.33K
Operating profit
78.57%-36.84K
37.39%-583.14K
67.47%-52.53K
12.02%-152.28K
17.43%-206.43K
50.43%-171.9K
68.47%-931.38K
66.24%-161.5K
72.74%-173.08K
65.76%-250.01K
Net non-operating interest income expense
137.52%2.49K
64.97%-19.61K
94.63%-4.54K
17.69%21.65K
-77.70%4.68K
39.12%-6.62K
-4,297.80%-55.98K
89.02%-84.48K
-60.57%18.39K
104.13%20.99K
Non-operating interest expense
----
1,570.44%19.61K
----
----
----
----
-7.78%1.17K
----
----
----
Total other finance cost
-137.52%-2.49K
----
----
-17.69%-21.65K
77.70%-4.68K
--6.62K
--54.81K
--83.31K
60.57%-18.39K
-104.13%-20.99K
Other net income (expense)
96.60%-92.45K
98.93%-3.51K
94.84%-123.71K
-89.46%-2.72M
-327.57K
-2.4M
Gain on sale of security
----
-204.52%-3.51K
----
----
----
----
105.74%3.36K
----
----
----
Special income (charges)
----
96.74%-88.93K
--0
--0
94.84%-123.71K
----
-315.37%-2.73M
49.58%-330.93K
--0
---2.4M
-Gain on sale of property,plant,equipment
----
96.74%-88.93K
--0
--0
94.84%-123.71K
----
-315.37%-2.73M
49.58%-330.93K
--0
---2.4M
Income before tax
80.76%-34.35K
81.26%-695.2K
89.44%-60.58K
15.55%-130.63K
87.60%-325.46K
50.09%-178.52K
15.53%-3.71M
78.64%-573.55K
73.71%-154.69K
-111.83%-2.62M
Income tax
Net income
80.76%-34.35K
81.26%-695.2K
89.44%-60.58K
15.55%-130.63K
87.60%-325.46K
50.09%-178.52K
15.53%-3.71M
50.08%-573.55K
77.31%-154.69K
-111.83%-2.62M
Net income continuous Operations
80.76%-34.35K
81.26%-695.2K
89.44%-60.58K
15.55%-130.63K
87.60%-325.46K
50.09%-178.52K
15.53%-3.71M
50.08%-573.55K
77.31%-154.69K
-111.83%-2.62M
Minority interest income
Net income attributable to the parent company
80.76%-34.35K
81.26%-695.2K
89.44%-60.58K
15.55%-130.63K
87.60%-325.46K
50.09%-178.52K
15.53%-3.71M
50.08%-573.55K
77.31%-154.69K
-111.83%-2.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
80.76%-34.35K
81.26%-695.2K
89.44%-60.58K
15.55%-130.63K
87.60%-325.46K
50.09%-178.52K
15.53%-3.71M
50.08%-573.55K
77.31%-154.69K
-111.83%-2.62M
Basic earnings per share
83.33%-0.001
95.24%-0.02
0
79.01%-0.0042
99.25%-0.01
98.18%-0.006
88.30%-0.42
97.30%-0.0254
96.37%-0.02
-31.68%-1.33
Diluted earnings per share
83.33%-0.001
95.24%-0.02
0
79.01%-0.0042
99.25%-0.01
98.18%-0.006
88.30%-0.42
97.30%-0.0254
96.37%-0.02
-31.68%-1.33
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024(Q2)Feb 29, 2024(Q1)Nov 30, 2023(FY)Aug 31, 2023(Q4)Aug 31, 2023(Q3)May 31, 2023(Q2)Feb 28, 2023
Total revenue 0-68.29%130.07K0040.64K89.44K1,269.13%410.17K233.80%100K310.17K0
Operating revenue --0-68.29%130.07K--0--0--40.64K--89.44K1,269.13%410.17K233.80%100K--310.17K--0
Cost of revenue 6.22K0
Gross profit 34.42K0
Operating expense -85.90%36.84K-46.84%713.21K-79.91%52.53K-68.49%152.28K-3.67%240.85K-24.64%261.34K-55.04%1.34M-48.56%261.5K-23.90%483.25K-65.76%250.01K
Selling and administrative expenses -75.26%36.84K-43.03%518.43K-24.84%126.47K-50.31%109.39K-43.77%133.65K-47.55%148.92K-49.46%909.98K-51.19%168.26K-42.96%220.13K-40.53%237.68K
-Selling and marketing expense ------0-----------------92.35%1.22K------------
-General and administrative expense -75.26%36.84K-42.95%518.43K-24.29%126.47K-50.31%109.39K-43.77%133.65K-47.55%148.92K-49.08%908.76K-49.19%167.04K-42.96%220.13K-40.53%237.68K
Research and development costs --0-54.86%194.79K-179.30%-73.93K-83.70%42.88K769.56%107.2K78.76%112.42K-63.53%431.57K-43.01%93.24K5.64%263.12K-96.27%12.33K
Operating profit 78.57%-36.84K37.39%-583.14K67.47%-52.53K12.02%-152.28K17.43%-206.43K50.43%-171.9K68.47%-931.38K66.24%-161.5K72.74%-173.08K65.76%-250.01K
Net non-operating interest income expense 137.52%2.49K64.97%-19.61K94.63%-4.54K17.69%21.65K-77.70%4.68K39.12%-6.62K-4,297.80%-55.98K89.02%-84.48K-60.57%18.39K104.13%20.99K
Non-operating interest expense ----1,570.44%19.61K-----------------7.78%1.17K------------
Total other finance cost -137.52%-2.49K---------17.69%-21.65K77.70%-4.68K--6.62K--54.81K--83.31K60.57%-18.39K-104.13%-20.99K
Other net income (expense) 96.60%-92.45K98.93%-3.51K94.84%-123.71K-89.46%-2.72M-327.57K-2.4M
Gain on sale of security -----204.52%-3.51K----------------105.74%3.36K------------
Special income (charges) ----96.74%-88.93K--0--094.84%-123.71K-----315.37%-2.73M49.58%-330.93K--0---2.4M
-Gain on sale of property,plant,equipment ----96.74%-88.93K--0--094.84%-123.71K-----315.37%-2.73M49.58%-330.93K--0---2.4M
Income before tax 80.76%-34.35K81.26%-695.2K89.44%-60.58K15.55%-130.63K87.60%-325.46K50.09%-178.52K15.53%-3.71M78.64%-573.55K73.71%-154.69K-111.83%-2.62M
Income tax
Net income 80.76%-34.35K81.26%-695.2K89.44%-60.58K15.55%-130.63K87.60%-325.46K50.09%-178.52K15.53%-3.71M50.08%-573.55K77.31%-154.69K-111.83%-2.62M
Net income continuous Operations 80.76%-34.35K81.26%-695.2K89.44%-60.58K15.55%-130.63K87.60%-325.46K50.09%-178.52K15.53%-3.71M50.08%-573.55K77.31%-154.69K-111.83%-2.62M
Minority interest income
Net income attributable to the parent company 80.76%-34.35K81.26%-695.2K89.44%-60.58K15.55%-130.63K87.60%-325.46K50.09%-178.52K15.53%-3.71M50.08%-573.55K77.31%-154.69K-111.83%-2.62M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 80.76%-34.35K81.26%-695.2K89.44%-60.58K15.55%-130.63K87.60%-325.46K50.09%-178.52K15.53%-3.71M50.08%-573.55K77.31%-154.69K-111.83%-2.62M
Basic earnings per share 83.33%-0.00195.24%-0.02079.01%-0.004299.25%-0.0198.18%-0.00688.30%-0.4297.30%-0.025496.37%-0.02-31.68%-1.33
Diluted earnings per share 83.33%-0.00195.24%-0.02079.01%-0.004299.25%-0.0198.18%-0.00688.30%-0.4297.30%-0.025496.37%-0.02-31.68%-1.33
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Trending Stocks
Donald Trump Donald Trump

Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.